Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow Jrheum on BlueSky
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
Research ArticleArticle

Modified Framingham Risk Factor Score for Systemic Lupus Erythematosus

Murray B. Urowitz, Dominique Ibañez, Jiandong Su and Dafna D. Gladman
The Journal of Rheumatology May 2016, 43 (5) 875-879; DOI: https://doi.org/10.3899/jrheum.150983
Murray B. Urowitz
From the University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, Toronto, Ontario, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: m.urowitz@utoronto.ca
Dominique Ibañez
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jiandong Su
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dafna D. Gladman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
PreviousNext
Loading

REFERENCES

  1. 1.↵
    1. Manzi S,
    2. Meilahn EN,
    3. Rairie JE,
    4. Conte CG,
    5. Medsger TA Jr,
    6. Jansen-McWilliams L,
    7. et al.
    Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol 1997;145:408–15.
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    1. Goldberg RJ,
    2. Urowitz MB,
    3. Ibañez D,
    4. Nikpour M,
    5. Gladman DD
    . Risk factors for development of coronary artery disease in women with systemic lupus erythematosus. J Rheumatol 2009;11:2454–61.
    OpenUrl
  3. 3.↵
    1. Urowitz MB,
    2. Bookman AA,
    3. Koehler BE,
    4. Gordon DA,
    5. Smythe HA,
    6. Ogryzlo MA
    . The bimodal mortality pattern of systemic lupus erythematosus. Am J Med 1976;60:221–5.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Nikpour M,
    2. Urowitz MB,
    3. Gladman DD
    . Premature atherosclerosis in systemic lupus erythematosus [review]. Rheum Dis Clin North Am 2005;31:329–54, vii–viii.
    OpenUrlCrossRefPubMed
  5. 5.↵
    1. Esdaile JM,
    2. Abrahamowicz M,
    3. Grodzicky T,
    4. Li Y,
    5. Panaritis C,
    6. du Berger R,
    7. et al.
    Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum 2001;44:2331–7.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Bruce IN,
    2. Urowitz MB,
    3. Gladman DD,
    4. Hallett DC
    . Natural history of hypercholesterolemia in systemic lupus erythematosus. J Rheumatol 1999;26:2137–43.
    OpenUrlPubMed
  7. 7.↵
    1. Asanuma Y,
    2. Oeser A,
    3. Shintani AK,
    4. Turner E,
    5. Olsen N,
    6. Fazio S,
    7. et al.
    Premature coronary-artery atherosclerosis in systemic lupus erythematosus. N Engl J Med 2003;349:2407–15.
    OpenUrlCrossRefPubMed
  8. 8.↵
    1. Urowitz MB,
    2. Ibañez D,
    3. Gladman DD
    . Atherosclerotic vascular events in a single large lupus cohort: prevalence and risk factors. J Rheumatol 2007;34:70–5.
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    1. Urowitz MB,
    2. Gladman D,
    3. Ibañez D,
    4. Fortin P,
    5. Sanchez-Guerrero J,
    6. Bae S,
    7. et al;
    8. Systemic Lupus International Collaborating Clinics
    . Accumulation of coronary artery disease risk factors over three years: data from an international inception cohort. Arthritis Rheum 2008;59:176–80.
    OpenUrlCrossRefPubMed
  10. 10.↵
    1. Karp I,
    2. Abrahamowicz M,
    3. Fortin PR,
    4. Pilote L,
    5. Neville C,
    6. Pineau CA,
    7. et al.
    Recent corticosteroid use and recent disease activity: independent determinants of coronary heart disease risk factors in systemic lupus erythematosus? Arthritis Rheum 2008;59:169–75.
    OpenUrlCrossRefPubMed
  11. 11.↵
    1. Nikpour M,
    2. Urowitz MB,
    3. Ibañez D,
    4. Harvey PJ,
    5. Gladman DD
    . Importance of cumulative exposure to elevated cholesterol and blood pressure in development of atherosclerotic coronary artery disease in systemic lupus erythematosus: a prospective proof-of-concept cohort study. Arthritis Res Ther 2011;13:R156.
    OpenUrlCrossRefPubMed
  12. 12.↵
    1. Magder LS,
    2. Petri M
    . Incidence of and risk factors for adverse cardiovascular events among patients with systemic lupus erythematosus. Am J Epidemiol 2012;176:708–19.
    OpenUrlAbstract/FREE Full Text
  13. 13.↵
    1. D’Agostino RB Sr,
    2. Vasan RS,
    3. Pencina MJ,
    4. Wolf PA,
    5. Cobain M,
    6. Massaro JM,
    7. et al.
    General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 2008;117:743–53.
    OpenUrlAbstract/FREE Full Text
  14. 14.↵
    1. Ridker PM,
    2. Buring JE,
    3. Rifai N,
    4. Cook NR
    . Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. JAMA 2007;297:611–9.
    OpenUrlCrossRefPubMed
  15. 15.↵
    1. Gladman DD,
    2. Ibañez D,
    3. Urowitz MB
    . Systemic lupus erythematosus disease activity index 2000. J Rheumatol 2002;29:288–91.
    OpenUrlAbstract/FREE Full Text
  16. 16.↵
    1. Rubin DB
    . Multiple imputation for nonresponse in surveys. New York: John Wiley & Sons; 1987.
  17. 17.↵
    SAS Documentation. SAS version 9.3. 2011.
  18. 18.↵
    1. Rubin DB
    . Inference and missing data. Biometrika 1976;63:581–92.
    OpenUrlAbstract/FREE Full Text
  19. 19.↵
    1. Rubin DB
    . Multiple imputation after 18+ years. J Am Stat Assoc 1996;91:473–89.
    OpenUrlCrossRef
  20. 20.↵
    1. Barzi F,
    2. Woodward M
    . Imputations of missing values in practice: results from imputations of serum cholesterol in 28 cohort studies. Am J Epidemiology 2004;160:34–45.
    OpenUrlAbstract/FREE Full Text
  21. 21.↵
    1. Agresti A,
    2. Coull BA
    . Approximation is better than “exact” for interval estimation of binomial proportions. Am Stat 1998;52:119–26.
    OpenUrlCrossRef
  22. 22.↵
    1. Kleinbaum DG,
    2. Klein M
    . Survival analysis: a self-learning text, third edition. New York: Springer; 2012:241–88.
  23. 23.↵
    1. Grønnesby JK,
    2. Borgan O
    . A method for checking regression models in survival analysis based on the risk score. Lifetime Data Anal 1996;2:315–28.
    OpenUrlCrossRefPubMed
  24. 24.↵
    1. Kawai VK,
    2. Solus JF,
    3. Oeser A,
    4. Rho YH,
    5. Raggi P,
    6. Bian A,
    7. et al.
    Novel cardiovascular risk prediction models in patients with systemic lupus erythematosus. Lupus 2011;20:1526–34.
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top

In this issue

The Journal of Rheumatology
Vol. 43, Issue 5
1 May 2016
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Modified Framingham Risk Factor Score for Systemic Lupus Erythematosus
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Modified Framingham Risk Factor Score for Systemic Lupus Erythematosus
Murray B. Urowitz, Dominique Ibañez, Jiandong Su, Dafna D. Gladman
The Journal of Rheumatology May 2016, 43 (5) 875-879; DOI: 10.3899/jrheum.150983

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
Modified Framingham Risk Factor Score for Systemic Lupus Erythematosus
Murray B. Urowitz, Dominique Ibañez, Jiandong Su, Dafna D. Gladman
The Journal of Rheumatology May 2016, 43 (5) 875-879; DOI: 10.3899/jrheum.150983
del.icio.us logo Twitter logo Facebook logo  logo Mendeley logo
  • Tweet Widget
  •  logo
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • References
  • PDF

Keywords

SYSTEMIC LUPUS ERYTHEMATOSUS
CARDIOVASCULAR DISEASE
FRAMINGHAM RISK SCORE

Related Articles

Cited By...

More in this TOC Section

  • Multivariable Models to Predict a Diagnosis of Giant Cell Arteritis: Systematic Review and Metaanalysis
  • Prevalence and Predictors of Achieving Sustained Remission in Psoriatic Arthritis: A Swedish Nationwide Registry Study
  • Development of the Australian Rheumatology Association Clinical Care Standard for the Diagnosis and Management of Rheumatoid Arthritis in Adults
Show more Article

Similar Articles

Keywords

  • systemic lupus erythematosus
  • CARDIOVASCULAR DISEASE
  • FRAMINGHAM RISK SCORE

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2025 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire